Citations

Mayo Clinic

Showing 10 of 108376 citations.

Internal Carotid Artery Aneurysms in a Patient With Neurofibromatosis Type 1
Onkendi, Edwin, Moghaddam, Mahsa Bidgoli, Oderich, Gustavo S.

Vascular and Endovascular Surgery | May 18, 2010 | Volume: 44 | Issue: 6 | Pages: 511-514

10.1177/1538574410369567 | PMID 20484076 Get It

Neurofibromatosis type 1 (NF-1) is an autosomal dominant disorder characterized by café au lait macules, neurofibromas, and iris hamartomas. Internal carotid artery aneurysms rarely affect patients with NF-1 but may be associated with rupture or neurologic complications. We report a 42-year-old female patient with NF-1 and a bilobed right internal carotid artery aneurysm extending to C2. The aneurysm was excised with high exposure of the carotid artery and reconstruction was performed using saphenous vein graft. We review the literature relevant to internal carotid aneurysms associated with NF-1.
Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers
Harrington, Kevin J. , Karapanagiotou, Eleni , Roulstone, Victoria , Twigger, Katie, Vidal, Laura , Beirne, Debbie, Prestwich, Robin, Newbold, Kate, Ahmed, Merina , Thway, Khin , Nutting, Christopher M. , Vile, Richard G. , Pandha, Hardev , Bono, Johann S. de , Melcher, Alan , White, Christine L. , Coffey, Matt C. , Harris, Dean , Melcher, Alan A , Harrington, Kevin , de Bono, Johann

Clinical Cancer Research | May 18, 2010 | Volume: 16 | Issue: 11 | Pages: 3067-3077

10.1158/1078-0432.ccr-10-0054 | PMID 20484020 Get It

Abstract Purpose: To determine the safety and feasibility of combining intratumoral reovirus and radiotherapy in patients with advanced cancer and to assess viral biodistribution, reoviral replication in tumors, and antiviral immune responses. Experimental Design: Patients with measurable disease amenable to palliative radiotherapy were enrolled. In the first stage, patients received radiotherapy (20 Gy in five fractions) plus two intratumoral injections of RT3D at doses between 1 × 108 and 1 × 1010 TCID50. In the second stage, the radiotherapy dose was increased (36 Gy in 12 fractions) and patients received two, four, or six doses of RT3D at 1 × 1010 TCID50. End points were safety, viral replication, immunogenicity, and antitumoral activity. Results: Twenty-three patients with various solid tumors were treated. Dose-limiting toxicity was not seen. The most common toxicities were grade 2 (or lower) pyrexia, influenza-like symptoms, vomiting, asymptomatic lymphopenia, and neutropenia. There was no exacerbation of the acute radiation reaction. Reverse transcription-PCR (RT-PCR) studies of blood, urine, stool, and sputum were negative for viral shedding. In the low-dose (20 Gy in five fractions) radiation group, two of seven evaluable patients had a partial response and five had stable disease. In the high-dose (36 Gy in 12 fractions) radiation group, five of seven evaluable patients had partial response and two stable disease. Conclusions: The combination of intratumoral RT3D and radiotherapy was well tolerated. The favorable toxicity profile and lack of vector shedding means that this combination should be evaluated in newly diagnosed patients receiving radiotherapy with curative intent. Clin Cancer Res; 16(11); 3067–77. ©2010 AACR.
Projecting future drug expenditures—2010
Hoffman, James M. , Doloresco, Fred, Vermeulen, Lee C. , Shah, Nilay D., Matusiak, Linda M., Hunkler, Robert J., Schumock, Glen T.

American Journal of Health-System Pharmacy | May 18, 2010 | Volume: 67 | Issue: 11 | Pages: 919-928

10.2146/ajhp100068 | PMID 20484216 Get It

Retraction: TREM-2 Mediated Signaling Induces Antigen Uptake and Retention in Mature Myeloid Dendritic Cells
Arneson, Laura N., Upshaw, Jadee L., Howe, Charles L. , Felts, Sara J. , Rodriguez, Moses , Pease, Larry R. , Colonna, Marco , Colonna, Marco , Rodriguez, Moses , Howe, Charles L

The Journal of Immunology | May 18, 2010 | Volume: 184 | Issue: 11 | Pages: 6557-6557

10.4049/jimmunol.1090036 | PMID 20483797 Get It

Retraction: Reprogrammed FoxP3+ T Regulatory Cells Become IL-17+ Antigen-Specific Autoimmune Effectors In Vitro and In Vivo
Cabrera, Rosalyn, Schenk, Erin L. , Nava-Parada, Pilar , Bell, Michael P., Keulen, Virginia P. Van , Marler, Ronald J., Felts, Sara J. , Pease, Larry R.

The Journal of Immunology | May 18, 2010 | Volume: 184 | Issue: 11 | Pages: 6556-6556

10.4049/jimmunol.1090035 | PMID 20483796 Get It

Retraction: Induction of a Th1 Response from Th2-Polarized T Cells by Activated Dendritic Cells: Dependence on TCR:Peptide-MHC Interaction, ICAM-1, IL-12, and IFN-γ
Wiehagen, Karla R., Pulko, Vesna, Keulen, Virginia Van, Faubion, William A. , Knutson, Keith L. , Pease, Larry R. , Keulen, Virginia P. Van , Knutson, Keith L.

The Journal of Immunology | May 18, 2010 | Volume: 184 | Issue: 11 | Pages: 6555-6555

10.4049/jimmunol.1090034 | PMID 20483795 Get It

Retraction: B7-DC/PD-L2 Cross-Linking Induces NF-κB-Dependent Protection of Dendritic Cells from Cell Death
Nguyen, Loc T. , Ćirić, Bogoljub , Keulen, Virginia P. Van , Pease, Larry R.

The Journal of Immunology | May 18, 2010 | Volume: 184 | Issue: 11 | Pages: 6554-6554

10.4049/jimmunol.1090033 | PMID 20483794 Get It

Retraction: Blockade of Allergic Airway Inflammation Following Systemic Treatment with a B7-Dendritic Cell (PD-L2) Cross-Linking Human Antibody
Iijima, Koji, Rodriguez, Moses , Kita, Hirohito , Pease, Larry R. , Kobayashi, Takao , Kita, H , Rodriguez, Moses

The Journal of Immunology | May 18, 2010 | Volume: 184 | Issue: 11 | Pages: 6553-6553

10.4049/jimmunol.1090032 | PMID 20483793 Get It

Retraction: Naturally Occurring Human IgM Antibody That Binds B7-DC and Potentiates T Cell Stimulation by Dendritic Cells
Nguyen, Loc T. , Ćirić, Bogoljub , Ure, Daren , Zhou, Bin , Tamada, Koji , Tseng, Su-Yi, Shin, Tahiro, Dong, Haidong, Kyle, Robert A. , Rodriguez, Moses , Pease, Larry R. , Chen, Lieping , Rodriguez, Moses

The Journal of Immunology | May 18, 2010 | Volume: 184 | Issue: 11 | Pages: 6552-6552

10.4049/jimmunol.1090031 | PMID 20483792 Get It